Map Treatment Pathways Virtually – Engaging Your Advisors Creatively
May 22, 2025 | Advisory board, DOL engagement, HCP engagement, Impetus Digital, KOL Engagement, Pharma, Treatment, Virtual advisory board, advisor engagement, digital advisory board, life sciences, medical affairs, treatment mapping, treatment pathway, treatment profiling
Optimize product strategy! Discover how virtual profiling can accurately map treatment pathways and pinpoint opportunities for your innovations while engaging your advisors in a creative way!
Uncover critical insights into product placement and treatment algorithms. This video explores how to leverage virtual collaboration for comprehensive treatment pathway profiling, considering demographic, clinical, and regulatory factors. Empower your advisors to effectively map treatment sequencing and develop strategies for novel combination therapies.
-
Treatment Pathway Profiling
- Assess a product’s current and potential place in treatment algorithms.
- Integrate demographic, clinical, and regulatory/reimbursement factors.
- Create sequencing maps and treatment pathway profiles for various uses (medical education, poster presentations).
- Facilitate in-depth discussions on novel sequencing strategies and combination therapies.
For more creative ways to engage your advisors, visit: https://www.impetusdigital.com/2019/11/15/top-10-creative-ways-to-engage-your-advisors/
Learn more about Impetus Digital’s solutions: www.impetusdigital.com
Schedule a consultation: https://meetwithimpetus.com/
Stay connected:
- LinkedIn: https://linkedin.com/company/impetus-digital
- Twitter: https://twitter.com/impetus_digital
- Facebook: https://facebook.com/ImpetusDigital.fb
#TreatmentPathways #MedicalAffairs #PharmaStrategy #VirtualCollaboration #KOLEngagement #LifeSciences #ImpetusDigital
This content was provided by Impetus Digital
Company Details
Latest Content from Impetus Digital
Leadership Lessons Learned from the Pandemic
Alok Kanti, President & CEO of Bayer Canada, discusses a variety of topics, including his experience with leading an entire organization through the COVID-19 pandemic and where he sees digital health…
Overcoming Behavioral Health Access Limitations Through Telemedicine
Phil Hirsh, PhD, Founder & Chief Executive at Synergia Integrated teleBehavioral Health; and Craig Wright, MD, Senior Physician Executive and Consultant, discuss a range of topics surrounding telemedicine and other digital health…
Commercial Execution Strategies During & After the Pandemic
Frank Armenante, Director of Commercial Execution at Novo Nordisk, discusses a range of topics, from the impact of COVID-19 on commercial operations and the digitization of Pharma to his leadership lessons…
Top 10 Reasons Why Virtual Collaboration and Medical Education Will Persist in the New Normal
Even after the pandemic is long behind us, virtual collaboration will become mainstay in Pharma.
Pharma, Technology, and Healthcare in the New Normal
Brian Canestraro, General Manager at Intercept Pharmaceuticals, discusses a range of hot topics, from Brian’s leadership lessons and tips to the impact of the COVID-19 pandemic on the way that Pharma…
Solving the Caregiver Crisis Through Technology
Curtis Khan, CEO and Founder of BookJane, discusses the ongoing caregiver crisis and how BookJane’s solutions and other digital technologies can help to close this gap. We also delve into how…
Therapeutic VR for Managing Pain & Improving Patient Outcomes
Ramsay Brown, CEO and Founder of Quol, delves into several different HealthTech topics, including the concept of VR therapeutics and the importance of incorporating behavioral science and neuroscience into VR solutions, as…
Visual Storytelling in HealthTech
Rodney Hu, founder of 209|Digital and a popular podcast host. We explore Rodney’s work within the HealthTech space and what he believes has to happen for the healthcare industry to more…
Leveraging Digital Technologies to Create Valuable KOL Engagements & Empower Patients
Sandra Graham-Mason, Director of Marketing at Regeneron Pharmaceuticals discusses a variety of topics, from the impact of COVID-19 on the way that Pharma teams interact with internal stakeholders and KOLs to…
Roles of Neuroscience & AI in Solving Complex Healthcare Challenges
Dr. Phillip Alvelda, CEO and Co-Founder of Brainworks, discusses all things artificial intelligence and machine learning. We also explore the concepts of whole-brain AI systems and ambient biometrics, and how AI-enhanced vital…